Phase 4 N=52 Role of Pepsin Assay in Wheezy Infants
Gastroesophageal Reflux Disease
Primary: Number of Participants in Each Level of Wheeze Control — 18; 11; 9 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=64 The Effects of Dexmedetomidine on the Heart Beat During Elective Surgery in Children
Myocardial Repolarization · Healthy
Primary: Myocardial Repolarization (QTc and TP-e Intervals) 1min After Intervention — 67.8; 64.0; 64.3; 66.3 ms
Phase 4 N=100 Neuromuscular Blockade on Shoulder Pain of Elderly
Malignant Neoplasms of Digestive Organs · Malignant Neoplasms of Female Genital Organs · Malignant Neoplasms of Male Genital Organs
Primary: Percentage of Patients Who Reported Shoulder Pain — 12; 10 percentage of participants
Phase 4 N=302 A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease
Dementia Associated With Cerebrovascular Disease
Primary: Double Blind (DB) Phase: Change From Baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog) Score (LOCF) at Week 24 — -2.06; -2.64 score on a…
Phase 4 N=18 Safety Study of Levocetirizine and Fexofenadine
Pruritus · Chronic Urticaria · Allergic Rhinitis
Primary: Pruritus as Assessed by the VAS Score — 11.5; 25.4; 46.0 mm
Phase 4 N=95 SCHEDULE Follow Up Visit 5-7 yr
Heart Transplantation
Primary: Measured Glomerular Filtration Rate (mGFR) — 74.7; 62.4 mL/min/1.73m2 — p=0.0043
Phase 4 N=49 Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars
Healthy Volunteers
Primary: Percentage of Participants With Lower Scar Severity in the Treated Cheek Compared to the Untreated Cheek — 81 percentage of participants
Phase 4 N=353 A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults
Hepatitis B
Primary: Immunogenicity of Hepatitis B Vaccine With Different Doses and Schedules in Healthy Young Adults — 1847.99; 839.27; 1244.8 mIU/ml — p=<0.05
Phase 4 N=12 Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK-0518-851)
Human Immunodeficiency Virus (HIV) Infection
Primary: Number of Participants With an Adverse Event (AE) — 0 Participants
Phase 4 N=41 An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
Seborrheic Keratosis
Primary: Subject Satisfaction — 21; 14; 4; 0 Participants
Phase 4 N=33 Impact of Oral Antibiotic Treatment on C. Difficile
C. Difficile · Diarrhea · Enterocolitis
Primary: Change in Total Median Total Colony Forming Units (CFU) of C. Difficile Identified in the Hospital Room Environment for Each Antibiotic Treatment Group. — 56; 33; 149; 7…
Phase 4 N=715 A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Hyperplasia · Overactive Bladder
Primary: Change From Baseline to End of Treatment (EoT) in Mean Number of Micturitions Per Day — -2.00; -1.62 micturitions per day — p=0.039
Phase 4 N=19 Hypoxic Pulmonary Vasoconstriction Pilot Study
Emphysema
Primary: Perfused Blood Volume Assessed for a Change in Lung Inflammation Pre and Post Dose Sildenafil Administration — 0.37; 0.42 coefficient of variation — p=<0.05
Phase 4 N=104 Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)
Heart Failure
Primary: Number of Participants Taking Ivabradine at 180 Days — 6; 21 Participants — p=0.002
Phase 4 N=85 Inpatient Diabetes on Corticosteroids
Diabetes Mellitus
Primary: Mean POC Glucose Level Between Groups — 225; 266 mg/dl